Showing 1 - 2 results of 2 for search 'Eric J. Lawitz', query time: 0.02s Refine Results
  1. 1
    Pharmacokinetics, safety, and tolerability of BMS‐986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairment

    Pharmacokinetics, safety, and tolerability of BMS‐986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairment by Hisham Qosa, Claudia H. M. C. deOliveira, Giovanni Cizza, Eric J. Lawitz, Nicholas Colletti, Jeffrey Wetherington, Edgar D. Charles, Giridhar S. Tirucherai

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Phase 1 pharmacokinetic and safety study of soticlestat in participants with mild or moderate hepatic impairment or normal hepatic function

    Phase 1 pharmacokinetic and safety study of soticlestat in participants with mild or moderate hepatic impairment or normal hepatic function by Wei Yin, Pranab Mitra, Veronique Copalu, Thomas C. Marbury, Juan Carlos Rondon, Eric J. Lawitz, Valerie Lloyd, Mike Baratta, Mahnaz Asgharnejad, Tom Hui, Yasir Khan

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: